Tumor diagnosis and treatment have now moved into the era of precision medicine, and several molecular markers such as BRAF, RAS, RET/PTC, and PAX8/PPARγ have been used to improve the accuracy and timeliness of thyroid nodule diagnosis, as well as to reach the molecular level of the subtype classification of PTC. The gene discussed is BRAF; the disease is thyroid nodule.